Literature DB >> 23319547

The flinders sensitive line rat model of depression--25 years and still producing.

David H Overstreet1, Gregers Wegener.   

Abstract

Approximately 25 years have passed since the first publication suggesting the Flinders sensitive line (FSL) rat as an animal model of depression. At least 6 years of research on these rats was completed before that seminal paper, and there has been a steady stream of publications (130+) over the years. The present review will focus on several issues not previously covered in earlier reviews, summarize the several lines of ongoing investigations, and propose a novel mechanism that accounts for a number of previously unexplained observations. A key observation in the FSL rat relates to the antidepressant (AD)-like effects of known and putative antidepressants. The FSL rat typically exhibits an AD-like effect in behavioral tests for AD-like activity following chronic (14 days) treatment, although some studies have found AD-like effects after fewer days of treatment. In other observations, exaggerated swim test immobility in the FSL rat has been found to have a maternal influence, as shown by cross-fostering studies and observations of maternal behavior; the implications of this finding are still to be determined. Ongoing or recently completed studies have been performed in the laboratories of Marko Diksic of Canada, Aleksander Mathé of Sweden, Gregers Wegener of Denmark, Brian Harvey of South Africa, Paul Pilowsky and Rod Irvine of Australia, and Gal Yadid of Israel. Jennifer Loftis of Portland, Oregon, and Lynette Daws of San Antonio, Texas, have been working with the FSL rats in the United States. A puzzling feature of the FSL rat is its sensitivity to multiple chemicals, and its greater sensitivity to a variety of drugs with different mechanisms of action. It has been recently shown that each of these drugs feeds through G protein-coupled receptors to potassium-gated channels. Thus, an abnormality in the potassium channel could underlie the depressed-like behavior of the FSL rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319547     DOI: 10.1124/pr.111.005397

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  59 in total

1.  Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Francois Viljoen; Susanna M Ellis; Christiaan B Brink
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

Review 2.  Brain histamine modulates recognition memory: possible implications in major cognitive disorders.

Authors:  Gustavo Provensi; Alessia Costa; Ivan Izquierdo; Patrizio Blandina; Maria Beatrice Passani
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

Review 3.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

4.  S-Ketamine Reverses Hippocampal Dendritic Spine Deficits in Flinders Sensitive Line Rats Within 1 h of Administration.

Authors:  Giulia Treccani; Maryam Ardalan; Fenghua Chen; Laura Musazzi; Maurizio Popoli; Gregers Wegener; Jens Randel Nyengaard; Heidi Kaastrup Müller
Journal:  Mol Neurobiol       Date:  2019-04-29       Impact factor: 5.590

5.  Exacerbation of brain pathology after partial restraint in hypertensive rats following SiO₂ nanoparticles exposure at high ambient temperature.

Authors:  Hari S Sharma; Dafin F Muresanu; Ranjana Patnaik; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2013-07-06       Impact factor: 5.590

6.  Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.

Authors:  Kristian Gaarn du Jardin; Nico Liebenberg; Heidi Kaastrup Müller; Betina Elfving; Connie Sanchez; Gregers Wegener
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

7.  A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activity.

Authors:  Adriane F Brito; Patrícia C C S Braga; Lorrane K S Moreira; Dayane M Silva; Daiany P B Silva; Germán Sanz; Boniek G Vaz; Flávio S de Carvalho; Luciano M Lião; Rafaela R Silva; François Noël; Hiasmin F S Neri; Paulo C Ghedini; Murilo F de Carvalho; Eric de S Gil; Elson A Costa; Ricardo Menegatti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-19       Impact factor: 3.000

Review 8.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

Review 9.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 10.  Adaptations in reward-related behaviors and mesolimbic dopamine function during motherhood and the postpartum period.

Authors:  Millie Rincón-Cortés; Anthony A Grace
Journal:  Front Neuroendocrinol       Date:  2020-04-16       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.